Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $121.21 million. The enterprise value is $126.49 million.
| Market Cap | 121.21M |
| Enterprise Value | 126.49M |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.63 million shares outstanding. The number of shares has increased by 3.03% in one year.
| Current Share Class | 16.63M |
| Shares Outstanding | 16.63M |
| Shares Change (YoY) | +3.03% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 36.00% |
| Owned by Institutions (%) | 39.73% |
| Float | 10.64M |
Valuation Ratios
The trailing PE ratio is 13.54 and the forward PE ratio is 9.47.
| PE Ratio | 13.54 |
| Forward PE | 9.47 |
| PS Ratio | 0.73 |
| Forward PS | 0.60 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | 8.85 |
| P/OCF Ratio | 7.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.74, with an EV/FCF ratio of 9.24.
| EV / Earnings | 14.07 |
| EV / Sales | 0.77 |
| EV / EBITDA | 7.74 |
| EV / EBIT | 10.21 |
| EV / FCF | 9.24 |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.30 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 0.88 |
| Interest Coverage | 7.39 |
Financial Efficiency
Return on equity (ROE) is 7.04% and return on invested capital (ROIC) is 5.22%.
| Return on Equity (ROE) | 7.04% |
| Return on Assets (ROA) | 4.44% |
| Return on Capital (ROIC) | 5.22% |
| Revenue Per Employee | $308,119 |
| Profits Per Employee | $16,774 |
| Employee Count | 536 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, Ultralife has paid $1.89 million in taxes.
| Income Tax | 1.89M |
| Effective Tax Rate | 17.34% |
Stock Price Statistics
The stock price has increased by +8.32% in the last 52 weeks. The beta is 0.96, so Ultralife's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +8.32% |
| 50-Day Moving Average | 8.15 |
| 200-Day Moving Average | 9.75 |
| Relative Strength Index (RSI) | 36.76 |
| Average Volume (20 Days) | 54,034 |
Short Selling Information
The latest short interest is 151,827, so 0.91% of the outstanding shares have been sold short.
| Short Interest | 151,827 |
| Short Previous Month | 168,360 |
| Short % of Shares Out | 0.91% |
| Short % of Float | 1.43% |
| Short Ratio (days to cover) | 2.95 |
Income Statement
In the last 12 months, Ultralife had revenue of $165.15 million and earned $8.99 million in profits. Earnings per share was $0.54.
| Revenue | 165.15M |
| Gross Profit | 43.12M |
| Operating Income | 12.39M |
| Pretax Income | 12.33M |
| Net Income | 8.99M |
| EBITDA | 16.33M |
| EBIT | 12.39M |
| Earnings Per Share (EPS) | $0.54 |
Balance Sheet
The company has $6.77 million in cash and $12.06 million in debt, giving a net cash position of -$5.28 million or -$0.32 per share.
| Cash & Cash Equivalents | 6.77M |
| Total Debt | 12.06M |
| Net Cash | -5.28M |
| Net Cash Per Share | -$0.32 |
| Equity (Book Value) | 134.63M |
| Book Value Per Share | 8.09 |
| Working Capital | 60.23M |
Cash Flow
In the last 12 months, operating cash flow was $16.02 million and capital expenditures -$2.33 million, giving a free cash flow of $13.69 million.
| Operating Cash Flow | 16.02M |
| Capital Expenditures | -2.33M |
| Free Cash Flow | 13.69M |
| FCF Per Share | $0.82 |
Margins
Gross margin is 26.11%, with operating and profit margins of 7.50% and 5.44%.
| Gross Margin | 26.11% |
| Operating Margin | 7.50% |
| Pretax Margin | 6.61% |
| Profit Margin | 5.44% |
| EBITDA Margin | 9.89% |
| EBIT Margin | 7.50% |
| FCF Margin | 8.29% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.03% |
| Shareholder Yield | -3.03% |
| Earnings Yield | 7.42% |
| FCF Yield | 11.30% |
Analyst Forecast
The average price target for Ultralife is $14.00, which is 92.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 92.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 3.77 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.77 |
| Piotroski F-Score | 7 |